Sterling Capital Management LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1329883 CHARLOTTE, NC

Position in VRTX

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$5,955,950

-$1,996,891 QoQ

Shares Held

13,338

-24.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 53.01394511920827.ToString("F0")% Shared 0.ToString("F0")% None 46.98605488079172.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sterling Capital Management LLC holds $38,253,389 across 229 Biotechnology names. VRTX ranks #2 (15.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	12,738	$9,841,888
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	13,338	$5,955,950
3	ASND	Ascendis Pharma A/S	14,929	$3,414,710
4	JAZZ	Jazz Pharmaceuticals plc	14,615	$2,762,965
5	INSM	INSMED Inc	12,993	$2,124,615
6	ALNY	Alnylam Pharmaceuticals, Inc.	5,182	$1,714,568
7	RVMD	Revolution Medicines, Inc.	11,343	$1,103,106
8	VCEL	Vericel Corp	31,635	$1,017,697

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,955,950	13,338	-24.0%	Shares	Sole	2026-04-22
2025-12-31	$7,952,841	17,542	+0.4%	Shares	Sole	2026-02-13
2025-09-30	$6,845,083	17,478	-14.5%	Shares	Sole	2025-11-12
2025-06-30	$9,101,668	20,444	+65.2%	Shares	Sole	2025-08-08
2025-03-31	$5,999,162	12,374	+3.1%	Shares	Sole	2025-05-13
2024-12-31	$4,831,997	11,999	-2.4%	Shares	Sole	2025-02-13
2024-09-30	$5,715,833	12,290	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.